Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial.
Journal
Nature cancer
Journal Volume
6
Journal Issue
5
Start Page
907
ISSN
2662-1347
Date Issued
2025-05
Author(s)
Kim, Won Seog
Kim, Tae Min
Cho, Seok-Goo
Jarque, Isidro
Iskierka-Jażdżewska, Elżbieta
Poon, Li Mei
Prince, H Miles
Zhang, Huilai
Cao, Junning
Zhang, Mingzhi
Tessoulin, Benoît
Oh, Sung Yong
Lim, Francesca
Carpio, Cecilia
Tan, Tran-Der
Ayyappan, Sabarish
Gutierrez, Antonio
Cai, Jingxian
Ufkin, Melanie
Shariff, Saleem
Brouwer-Visser, Jurriaan
Chaudhry, Aafia
Mohamed, Hesham
Ambati, Srikanth
Walewski, Jan
et al.
Type
corrigendum